Skip to content
Medical Health Aged Care

Dementia set to become Australia’s leading cause of death, cementing need for investment in prevention

Dementia Australia 2 mins read

The latest data from the Australian Bureau of Statistics (ABS) released today highlights the urgent reality of dementia in Australia, revealing dementia is set to become the nation’s leading cause of death.

In 2023, dementia accounted for 9.1 per cent of all deaths, closely following ischaemic heart disease at 9.2 per cent. Dementia remains the leading cause of death for Australian women, representing 12.2 per cent of all female deaths and 6.4 per cent of male deaths.

The figures also show that dementia is now the leading cause of death in South Australia, the Australian Capital Territory, and, for the first time, New South Wales.

Dementia Australia CEO Professor Tanya Buchanan said that, given there is no cure for dementia and poor community understanding of the terminal nature of the disease, the ABS data reinforces the urgent need for a public health approach to reducing – or preventing - the risk of developing dementia.

“This call is backed by the 2024 update of the Lancet Commission on the prevention, treatment, and care of dementia, which reports that almost half of dementia cases worldwide could be prevented or delayed,” Professor Buchanan said.

“There are currently an estimated 421,000 Australians living with dementia and without a significant intervention, this number is expected to increase to more than 812,500 by 2054.

“As dementia edges closer to becoming the leading cause of death of Australians, it is crucial that we act now to focus on the brain health of the nation as well as provide more targeted, effective support to those impacted by dementia. Taking this dual approach will ensure we are working towards reducing the impact of dementia in the future.

“Australians currently impacted by dementia can access support now by contacting the National Dementia Helpline on 1800 100 500, 24 hours a day, seven days a week.”

-Ends-

Dementia Australia is the source of trusted information, education and services for the estimated more than 421,000 Australians living with dementia, and the more than 1.6 million people involved in their care. We advocate for positive change and support vital research. We are here to support people impacted by dementia, and to enable them to live as well as possible. No matter how you are impacted by dementia or who you are, we are here for you.

For support, please contact the National Dementia Helpline on 1800 100 500. An interpreter service is available. The National Dementia Helpline is funded by the Australian Government. People looking for information can also visit dementia.org.au

Media contacts: Stephen O’Connell, Media and Communications Advisor, Dementia Australia – Stephen.OConnell@dementia.org.au, 0402 284 257

When talking or writing about dementia please refer to Dementia-Friendly Language Guidelines.

Note to Editors:
We request, where possible, details for the National Dementia Helpline 1800 100 500 appear alongside news stories about dementia, as these stories often prompt questions or concerns:

If this story has prompted any questions or concerns, please call the National Dementia Helpline 1800 100 500 (24 hours, 7 days a week) or visit dementia.org.au.

More from this category

  • Disability, Medical Health Aged Care
  • 20/12/2024
  • 17:36
Kuremara

Kuremara to Open a State-of-the-Art Activity Center in Milton, QLD, in January 2025

Kuremara, a trusted and leading NDIS-registered provider in Australia, is excited to announce the opening of its newest facility—a cutting-edge activity center in Milton,…

  • Contains:
  • Legal, Medical Health Aged Care
  • 20/12/2024
  • 17:29
JGA Saddler

BREAKING NEWS: Australian law firm takes on Johnson & Johnson for selling Australians ineffective medicine

Vision available: Lawyer and doctor VNR, editorial photos and radio grabs included can be found in this SharePoint File In-person lawyer interviews available by…

  • Contains:
  • Medical Health Aged Care
  • 20/12/2024
  • 12:01
NDARC/UNSW

ADHD drug shows promise for treating methamphetamine dependence, landmark Australian study shows

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first pharmacotherapy for people with methamphetamine dependence, according to a study published in Addiction. Results from the landmark ‘LiMA’ trial show that thepsychostimulant lisdexamfetamine can drastically reduce the need to use methamphetamine among those who are dependent on the illicit drug. Lead author and addiction medicine specialist Professor Nadine Ezard, who is Director of the National Centre for Clinical Research on Emerging Drugs (NCCRED), said the results were promising. "There is currently no pharmacotherapy approved for treating methamphetamine dependence," Professor Ezard said. “While further…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.